Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Non-Exudative Type 1 Macular Neovascularization (MNV) on Age-related Macular Degeneration (AMD) Progression

NCT06125977 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT06125977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06125977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Non-Exudative Type 1 Macular Neovascularization (MNV) on Age-related Macular Degeneration (AMD) Progression
Lead sponsor
University of Utah
Phase
Observational
Overall status
Active, not recruiting
Start date
January 30, 2023
Completion date
August 31, 2027
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, neovascularization, choroidal